Is Precigen’s (PGEN) New PAPZIMEOS J-Code Reframing Its Respiratory Growth Narrative?

The Market Sold Off Hard. Then It Recovered Fast. Here's What That Cycle Tells You About Staying Invested Through the Next Crisis.

Neogen (NEOG) Is Down 7.9% After Raising 2026 Revenue Guidance Amid Wider Net Loss And New CLO – Has The Bull Case Changed?

Stocks Climb to New Records With Investors Piling Back Into Tech

Bulls Roll On, Chip Giant Breaks Out; Netflix Dives Late

S&P 500's all-time high, investigators visit the Fed, Allbirds' rebrand and more in Morning Squawk